VC funding of digital health hit record USD 9.5 billion in 2018
Venture capital funding for digital health companies grew to $9.5 billion in 2018, up 32% from $7.2 billion in 2017, according to Mercom Capital Group, a global communications and research firm.
Alex Guest Wed, 16/01/2019 - 08:52
JPND announces €30 million call for neurodegenerative disease research
JPND, the EU's neurodegenerative disease research initiative, has announced a €30 million call for multinational research on personalised medicine for neurodegenerative diseases.
Alex Guest Wed, 09/01/2019 - 09:34
HealthTech wearables to major at CES 2019

The Consumer Electronics Show (CES) 2019 kicks off in Las Vegas today, and will feature some advances in healthtech wearables. Amongst these are a collaboration between Garmin and Daimler, and a new product launch from Flint Rehab.

Alex Guest Tue, 08/01/2019 - 10:18

NHS Long Term Plan harnesses tech to prevent disease

The UK's NHS has today published its Long Term Plan, which sets out a vision to save half a million lives 'with practical action on major killer conditions and investment in world class, cutting edge treatments' over the next decade. At the heart of the plans is the use of technology for a wide range of purposes from telehealth to genomic screening.

Oxford Nanopore Technology genomics device reveals sources of Lassa outbreak

Research carried out during the 2018 Lassa fever outbreak in Nigeria used rapid, portable genomic sequencing technology to identify viruses without prior knowledge of the cause of disease. This enabled researchers to allay fears and direct the public health interventions to limit the spread of the virus and help to protect more people from disease.

Verily announces USD 1 billion investment round

Verily, an Alphabet portfolio company, has closed a $1 billion external funding round led by Silver Lake. The capital will be used to invest in strategic partnerships, in business development, and acquisitions.